Silence Therapeutics (SLN) Return on Capital Employed Growth (1y) (2026)

Silence Therapeutics (SLN) Return on Capital Employed Growth (1y) (2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (1y) (Qtr)
1 Oculis Holding AG 68,725.60 Bn 68,725.31 Bn - 1,648.00
2 Nanobiotix 1,953.19 Bn 1,953.13 Bn - -
3 Akari Therapeutics 1,132.35 Bn 1,132.35 Bn - 31,429.00
4 BeOne Medicines 472.73 Bn 467.94 Bn 1.35 Bn 1,805.00
5 Vertex Pharmaceuticals 123.52 Bn 116.27 Bn 2.59 Bn 2,503.00
6 Regeneron Pharmaceuticals 69.74 Bn 60.99 Bn 3.31 Bn -105.00
7 Belite Bio 63.09 Bn 63.09 Bn - -
8 Argenx Se 56.42 Bn 51.24 Bn 1.41 Bn -
9 Revolution Medicines 37.76 Bn 37.76 Bn - -3,457.00
10 Silence Therapeutics 1.64 Bn 1.51 Bn 411,000.00 -2,018.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -2,018.00